Vaxart, Inc. Retained Earnings
Vaxart, Inc. (VXRT) had Retained Earnings of -$468.51 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$468.51M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$455.02M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$460.19M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$515.24M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$468.51M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$455.02M S-1 · filed 2026-05-08 | |
| 2025-12-31 | -$460.19M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$515.24M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$507.10M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$492.11M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$476.52M S-1 · filed 2026-05-08 | |
| 2024-09-30 | -$464.54M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$450.46M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$433.99M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$409.57M 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$392.20M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | -$374.80M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | -$352.25M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | -$327.11M 10-K · filed 2024-03-14 | |
| 2022-09-30 | -$303.19M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$273.88M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | -$244.45M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | -$219.35M 10-K · filed 2023-03-15 | |
| 2021-09-30 | -$198.59M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$181.00M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$164.89M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$148.88M 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$135.02M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$126.94M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$117.96M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | -$116.66M 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$110.25M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$104.99M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$99.36M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$97.99M 10-K · filed 2020-03-19 | |
| 2018-09-30 | -$93.09M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$86.54M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | -$77.67M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$79.98M 10-K · filed 2019-02-06 | -$172.50M 10-Q · filed 2018-02-06 |
| 2017-09-30 | -$169.10M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$163.80M 10-Q · filed 2018-02-06 | |
| 2017-03-31 | -$157.80M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$153.40M 10-Q · filed 2017-02-06 | |
| 2016-09-30 | -$144.30M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | -$134.30M 10-K · filed 2017-09-01 | |
| 2016-03-31 | -$127.30M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$122.10M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | -$115.50M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | -$108.90M 10-K · filed 2016-09-13 | |
| 2015-03-31 | -$89.00M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | -$90.20M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | -$96.70M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$89.80M 10-K · filed 2015-09-11 | |
| 2014-03-31 | -$79.60M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$82.80M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | -$82.50M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$78.80M 10-K · filed 2014-09-30 | -$78.60M 10-K · filed 2013-09-27 |
| 2013-03-31 | -$72.10M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$72.31M 10-Q · filed 2013-02-11 | |
| 2012-09-30 | -$235.34M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$69.90M 10-K · filed 2013-09-27 | -$231.25M 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$228.51M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$228.08M 10-Q · filed 2012-11-08 | |
| 2011-09-24 | -$226.09M 10-Q · filed 2011-11-02 | |
| 2011-06-25 | -$226.17M 10-Q · filed 2011-08-03 | |
| 2010-12-25 | -$223.55M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |